'It seemed a fitting way to celebrate something he loved while raising awareness of brain tumours.'
with his active dad Chris.
So when his father passed away at the age of 62 earlier this year, Mark decided to honour their passion by embarking on a 274-mile cycle – with his dad’s ashes in tow. The pair were more than just father and son, they were best friends – with Chris attending Mark’s wedding last year as best man. But shortly after the family celebration, Chris was struck down by headaches and was diagnosed with a chronicThe 62-year-old died just four months later, on July 15, at Ystrad Mynach Hospital near Caerphilly.
Two days after his funeral, Mark set off on Chris’ mountain bike with his ashes on the month-long cycle ride around Wales – not only to honor his dad, but to also raise money for Brain Tumour Research.Mark, from Rogerstone, Gwent, said: ‘Dad was active, he used to run and loved cycling. When I saw the challenge it seemed a fitting way to celebrate something he loved while raising awareness of brain tumours.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
On this day in 2019: Ben Stokes seals an Ashes win for the agesStokes’ unbeaten 135 – and 76-run partnership with Jack Leach (1no) – earned an unforgettable victory over Australia at Headingley.
Læs mere »
On this day in 2019: Ben Stokes seals an Ashes win for the agesStokes’ unbeaten 135 – and 76-run partnership with Jack Leach (1no) – earned an unforgettable victory over Australia at Headingley.
Læs mere »
Farke's transfer update as Leeds United head into final week on 'right path'The Leeds United manager would not be drawn on the club's Joel Piroe interest, but struck an optimistic tone ahead of the final week of the transfer window
Læs mere »
FIFA open disciplinary proceedings against Rubiales over World Cup final kissThe President of the Spanish FA kissed Jennifer Hermoso on the lips.
Læs mere »
Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancerA novel antibody-drug conjugate continues to demonstrate superior benefit for patients with HR+, HER2- metastatic breast cancer when compared to standard chemotherapy, according to a new study in The Lancet.
Læs mere »